SA, D., DC, N., F, J., E, O. H., WC, M., MJ, V. d. B., . . . OC, M. (2026). Cardiotoxicity of trametinib monotherapy in adults with neurofibromatosis type 1: Results from the TRAIN study. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 198, 119251. https://doi.org/10.1016/j.biopha.2026.119251
Chicago Style (17th ed.) CitationSA, Ditta, et al. "Cardiotoxicity of Trametinib Monotherapy in Adults with Neurofibromatosis Type 1: Results from the TRAIN Study." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 198 (2026): 119251. https://doi.org/10.1016/j.biopha.2026.119251.
MLA (9th ed.) CitationSA, Ditta, et al. "Cardiotoxicity of Trametinib Monotherapy in Adults with Neurofibromatosis Type 1: Results from the TRAIN Study." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 198, 2026, p. 119251, https://doi.org/10.1016/j.biopha.2026.119251.